Cantor Fitzgerald Comments on AbbVie FY2025 Earnings
AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note issued to investors on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould forecasts that the company will post earnings per share of $12.33 for the year. Cantor Fitzgerald […]
